Nicotine 2 mg/1

Nicotine Polacrilex Lozenges 2 mg/1 help manage nicotine cravings for smoking cessation. These oral lozenges provide a controlled release of nicotine to support quitting smoking.

Nicotine Polacrilex Lozenges are designed to help individuals quit smoking by reducing nicotine cravings and withdrawal symptoms. These lozenges are used as part of a comprehensive smoking cessation program, which may include behavioral therapy and support. The primary use of nicotine lozenges is to provide a controlled dose of nicotine to help smokers gradually reduce their dependence on cigarettes.

Nicotine Polacrilex Lozenges work by delivering nicotine through the oral mucosa, which can help alleviate cravings and withdrawal symptoms associated with quitting smoking. Users may experience a reduction in the urge to smoke, as well as potential side effects such as nausea, headache, or throat irritation. The effects of the lozenge typically last for a period of time, helping to manage cravings throughout the day.

It is important to follow the recommended usage guidelines for Nicotine Polacrilex Lozenges to avoid potential side effects. Users should not exceed the recommended dose and should consult a healthcare provider before use, especially if they have any pre-existing medical conditions or are taking other medications. Pregnant or breastfeeding women should also seek medical advice before using nicotine lozenges.

Nicotine Polacrilex Lozenges may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. Users should be cautious when combining nicotine lozenges with other nicotine replacement therapies or stimulants. Additionally, alcohol and caffeine may affect the absorption and effectiveness of the lozenge, so users should be mindful of their consumption.